Blood–brain barrier: An impediment to neuropharmaceuticals
Aspirin use lowers the risk of colorectal cancer in some individuals
An attractive target for therapeutic intervention against HIV-1
Identifying location biomarkers
Enhanced tumor activity in metastatic melanoma
Combination treatment for HER2-negative, advanced breast cancer
2015–2020 Strategic Plan
2015 Annual Meeting Evaluation
2016 Call for Proposals
Call for Award Nominations
New member
Member of the Month
Dedicated Member
Career Profile
International Profile
The concept of fraction of drug transported (ft) with special emphasis on BBB efflux of CNS and antiretroviral drugs
Induction of both P-glycoprotein and specific cytochrome P450 by aspirin eventually does not alter the antithrombotic effect of clopidogrel
Response to “Induction of both P-glycoprotein and specific cytochrome P450 by Aspirin eventually does not alter the antithrombotic effect of clopidogrel”
Results From the IQ-CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase
Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier
Targeted delivery of protein and gene medicines through the blood–brain barrier
Radiopharmaceuticals for assessing ABC transporters at the blood–brain barrier
Viral sensing at the blood–brain barrier: New roles for innate immunity at the CNS vasculature
Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients
Regulation of ABC transporters at the blood–brain barrier
Justification of noninferiority margin: Methodology considerations in an exposure–response analysis
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: A model-based approach
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
Impact of OATP1B1, MDR1 and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects